Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients with Compensated Cirrhosis and a Sustained Response to Antiviral Therapy
Management of patients with cirrhosis includes endoscopic screening and surveillance to detect esophageal varices (EV) and prevent bleeding. However, the Baveno VI guidelines recommend avoiding endoscopies for patients with liver stiffness measurements below 20 kPa and platelet counts above 150,000 (favorable Baveno VI status) and endoscopic assessment of patients with higher levels of liver stiffness and platelet counts (unfavorable Baveno VI status). We aimed to validate the Baveno VI guidelines, evaluating outcomes of patients in the ANRS-CO12 CirVir cohort with compensated cirrhosis associated with hepatitis B virus (HBV) or hepatitis C virus (HCV) infection, with or without a sustained response to antiviral therapy.
Source: Gastroenterology - Category: Gastroenterology Authors: Dominique Thabut, Christophe Bureau, Richard Layese, Val érie Bourcier, Maryam Hammouche, Carole Cagnot, Patrick Marcellin, Dominique Guyader, Stanislas Pol, Dominique Larrey, Victor De Lédinghen, Denis Ouzan, Fabien Zoulim, Dominique Roulot, Albert Tra Source Type: research
More News: Antiviral Therapy | Bleeding | Cirrhosis | Endoscopy | Gastroenterology | Hepatitis | Hepatitis B | Hepatitis C | Liver | Urology & Nephrology